New CAR-T therapy trial offers hope for patients with aggressive lymphoma
Disease control
Recruiting now
This study is testing a new CAR-T cell therapy called TC011 for adults with aggressive B-cell lymphoma that has come back or hasn't responded to at least two prior treatments. The main goals are to find a safe dose and see if the therapy can shrink or eliminate tumors. It is for …
Phase: PHASE1, PHASE2 • Sponsor: TICAROS Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC